NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Managing Chronic Pain with TMS Therapy: A Drug-Free Solution
Chronic pain can significantly impact your quality of life, making everyday tasks difficult to manage. While many people rely on [...]
TMS Therapy for Managing Anxiety: A New Path to Calm
Anxiety disorders affect millions of people worldwide, often disrupting daily life and well-being. While traditional treatments like medication and therapy [...]
TMS Therapy and Depression: A Breakthrough in Mental Health Treatment
Depression is a pervasive mental health issue that affects millions of people worldwide, often requiring comprehensive and effective treatment strategies. [...]
Transforming ADHD Management with TMS Therapy: A Modern Approach
Attention Deficit Hyperactivity Disorder (ADHD) is a common condition that affects both children and adults, often making daily tasks challenging. [...]
Revolutionizing Chronic Pain Management with TMS Therapy
Chronic pain can be a debilitating condition that significantly impacts quality of life. Traditional pain management methods often involve medication, [...]
Enhancing PTSD Treatment with TMS Therapy: A New Hope
Post-Traumatic Stress Disorder (PTSD) is a serious mental health condition triggered by experiencing or witnessing traumatic events. While traditional treatments [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social